| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.10. | SOLESENCE, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 11.09. | Solésence Beauty Science win the inaugural Cosmetics Business Innovation Awards for Contract Manufacturing Partner of the Year | 13 | Cosmetics Business | ||
| 20.08. | SOLESENCE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.08. | Solesence Reports Q2 2026 Results: Full Earnings Call Transcript | 4 | Benzinga.com | ||
| 19.08. | Solésence, Inc.: Solésence Reports Second Quarter 2026 Financial Results | 658 | GlobeNewswire (Europe) | Quarterly Report Filed on Form 10-Q Company to Host Conference Call at 5:00 p.m. ET Today ROMEOVILLE, Ill., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically... ► Artikel lesen | |
| 19.08. | Solesence reports Q2 results | 1 | Seeking Alpha | ||
| SOLESENCE Aktie jetzt für 0€ handeln | |||||
| 19.08. | SOLESENCE, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 13.07. | Solésence, Inc.: Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp | 4 | GlobeNewswire (USA) | ||
| 10.07. | SOLESENCE, INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 18.06. | Solésence, Inc.: Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards | 7 | GlobeNewswire (USA) | ||
| 19.05. | Solésence, Inc.: Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Alle Awards, Marking Fourth Year of Recognition | 3 | GlobeNewswire (USA) | ||
| 15.05. | Solésence, Inc.: Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition | 2 | GlobeNewswire (USA) | ||
| 12.05. | SOLESENCE, INC. - 10-Q, Quarterly Report | 4 | SEC Filings | ||
| 12.05. | Solesence targets 30% gross margin floor while aiming to return to double-digit EBITDA margins by year-end 2026 | 2 | Seeking Alpha | ||
| 12.05. | Solesence GAAP EPS of -$0.01, revenue of $13M | 2 | Seeking Alpha | ||
| 12.05. | Solesence: Umsatzrückgang und Ergebnisverlust in Q1 2026 belasten Aktie | 4 | Investing.com Deutsch | ||
| 12.05. | Solesence Reports Q1 2026 Results: Full Earnings Call Transcript | 2 | Benzinga.com | ||
| 12.05. | SOLESENCE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.05. | Solésence, Inc.: Solésence Launches New Skin Health Technologies: WHSPR and Chromalüm | 8 | GlobeNewswire (USA) | ||
| 31.03. | Solésence, Inc.: Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results | 1.077 | GlobeNewswire (Europe) | Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 18,980 | -1,04 % | BioNTech, Formycon, Biogen - Pharma-Milliarden werden neu verteilt | Die Pharmaindustrie steht vor einer gewaltigen Neuordnung. Während milliardenschwere Blockbuster-Medikamente ihre Patentexklusivität verlieren, drängen günstigere Nachahmer-Präparate auf den Markt.... ► Artikel lesen | |
| ONTO INNOVATION | 193,35 | -2,42 % | Aletheia Capital initiates Nanometrics stock with buy on ALD growth | ||
| RIBER | 6,440 | +2,06 % | Riber Reports Improved Results For The First Half Of 2026 | RIBER REPORTS IMPROVED RESULTS FOR THE FIRST HALF OF 2026 Revenues of €12.7m (+19%) and gross margin of €5.1m (+31%), representing 39.8% of revenuesPositive net income of €0.2m, compared with -€0.8m... ► Artikel lesen | |
| NVE | 74,00 | +0,68 % | NVE Corporation: Aktie bricht vorbörslich um 25 % ein - Enttäuschende Quartalszahlen belasten | ||
| GOMSPACE | 1,204 | +6,36 % | GomSpace A/S: Ukraine's Sovereign Satellite Now Operating in Orbit | Ukraine's Sovereign Satellite Now Operating in Orbit
HIMERA and GomSpace launched it under the OBRIA Initiative.STOCKHOLM, Oct. 27, 2026 /PRNewswire/ -- Ukraine's HIMERA and Denmark's GomSpace... ► Artikel lesen | |
| KOPIN | 3,595 | +3,22 % | Fabric.AI (Nasdaq: FABC) Stockholders Ratify Kopin Strategic Partnership to Develop Neural I/o MicroLED Optical Interconnect Technology for Next Generation AI Data Centers | NEW YORK, NY, June 24, 2026 (GLOBE NEWSWIRE) -- Fabric.AI, Inc. (Nasdaq: FABC) ("Fabric.AI" or the "Company"), a fabless semiconductor company developing MicroLED-based optical interconnects for AI... ► Artikel lesen | |
| GAUZY | 6,000 | 0,00 % | GAUZY LTD: Gauzy Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal | TEL AVIV, Israel, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced receipt of a delisting... ► Artikel lesen | |
| SMOLTEK NANOTECH | 0,124 | +3,35 % | SMOLTEK NANOTECH HOLDING AB: Smoltek Now Traded on Nordic Growth Market (NGM) | ||
| ZENTEK | 0,342 | -3,93 % | Zentek Ltd.: Zentek Provides Corporate Update on Nasdaq Listing | Guelph, Ontario--(Newsfile Corp. - October 26, 2026) - Zentek Ltd. (TSXV: ZEN) (OTCQX: ZTEKF) ("Zentek" or the "Company") today provides an update on the Nasdaq appeal process it began after The Nasdaq... ► Artikel lesen | |
| VEECO INSTRUMENTS | 37,880 | -3,47 % | Veeco Instruments Inc.: Veeco Reports Second Quarter 2026 Financial Results | Second Quarter 2026 Highlights: Revenue of $193.5 million, compared with $166.1 million in the same period last yearGAAP net income of $11.9 million, or $0.18 per diluted share, compared with $11.7... ► Artikel lesen | |
| OBDUCAT | 0,031 | +10,71 % | NGM MARKET NOTICE: #26-72 Decision by the Disciplinary Committee regarding Obducat AB (publ) | ||
| ACACIA RESEARCH | 3,880 | +0,52 % | ACACIA RESEARCH CORP - 10-Q, Quarterly Report | ||
| ADVANCE ZINCTEK | 0,310 | 0,00 % | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | ||
| LAMPETIA | 0,141 | 0,00 % | EQS-Adhoc: Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten | EQS-Ad-hoc: Lampetia AG / Schlagwort(e): Sonstiges
Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten
16.07.2026 / 22:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
| NANOVIRICIDES | 1,250 | +2,46 % | As Ebola Spreads to Multiple Countries, the Importance of NV-387 Oral Gummies Treatment Cannot be Understated - Phase II Clinical Trial Advancing Towards the Second Part, Says NanoViricides | SHELTON, CT / ACCESS Newswire / October 27, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, explained... ► Artikel lesen |